美股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

ORUKA THERAPEUTICS INC

9.84

-0.2500-2.48%

成交量：4.45万

成交额：44.49万

市值：3.68亿

市盈率：-2.33

高：10.49

开：10.18

低：9.84

收：10.09

数据加载中...

总览公司新闻公告

公司资料

公司名字：

ORUKA THERAPEUTICS INC

交易所：

NASDAQ

成立时间：

- -

员工人数：

28

公司地址：

855 Oak Grove Avenue,Suite 100,Menlo Park,California,United States

官网：

http://orukatx.com

邮编：

94025

电话：

传真：

- -

简介：

Oruka Therapeutics, Inc.公司根据日期为2008年9月24日的协议和合并重组计划的条款完成了与ARCA Colorado的业务合并（合并），并于2008年10月28日进行了修订，其中Nuvelo，Inc.的全资子公司与ARCA Colorado合并，ARCA Colorado在合并后继续作为存续公司和Nuvelo，Inc.的全资子公司。紧随合并后，该公司从Nuvelo，Inc.更名为ARCA Biopharma，Inc.。Nuvelo最初注册成立为HYSEQ。该公司是一家临床阶段的生物制药公司，专注于开发针对银屑病、炎症和免疫学适应症的新型单克隆抗体疗法。

董事

名称

职位

Michael R. Bristow

President and Chief Executive Officer and Director

Robert E. Conway

Director, Chairman

Anders Hove

Director

Dan J. Mitchell

Director

Jacob Ma Weaver

Director

James Flynn

Director

Linda Grais

Director

Raymond L. Woosley

Director

股东

名称

职位

Michael R. Bristow

President and Chief Executive Officer and Director

Thomas A. Keuer

Chief Operating Officer

C. Jeffrey Dekker

Chief Financial Officer

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"澳洲华人首选美澳港股一站式交易平台 | 老虎证券","description":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","keywords":"老虎证券,老虎证券澳洲,老虎证券股票,老虎证券开户,老虎证券app,tigertrade老虎证券,股票,asx美股,炒股,券商,澳洲股票交易,澳大利亚炒股","social":{"ogDescription":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/ORKA/company"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"ORKA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ORKA\",,,,,undefined,":{"symbol":"ORKA","market":"US","secType":"STK","nameCN":"ORUKA THERAPEUTICS INC","latestPrice":9.84,"timestamp":1745858085103,"preClose":10.09,"halted":0,"volume":44503,"delay":0,"floatShares":24529621,"shares":37440510,"eps":-4.225857,"marketStatus":"交易中","change":-0.25,"latestTime":"04-28 12:34:59 EDT","open":10.18,"high":10.49,"low":9.835,"amount":444908.284295,"amplitude":0.064916,"askPrice":9.88,"askSize":136,"bidPrice":9.84,"bidSize":161,"shortable":3,"etf":0,"ttmEps":-4.225857,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1745870400000},"marketStatusCode":2,"adr":0,"listingDate":871012800000,"exchange":"NASDAQ","adjPreClose":10.09,"preHourTrading":{"tag":"盘前","latestPrice":9.93,"preClose":10.09,"latestTime":"04:40 EDT","volume":3,"amount":31.809998999999998,"timestamp":1745829655302},"postHourTrading":{"tag":"盘后","latestPrice":10.09,"preClose":10.09,"latestTime":"16:05 EDT","volume":330,"amount":3329.7,"timestamp":1745611507319},"volumeRatio":0.416448,"impliedVol":0.8821,"impliedVolPercentile":0.6512},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ORKA\",,,,,undefined,":{"symbol":"ORKA","floatShares":24529621,"roa":"--","roe":"--","lyrEps":-3.873702,"volumeRatio":0.416448,"shares":37440510,"dividePrice":0,"high":10.49,"amplitude":0.064916,"preClose":10.09,"low":9.835,"week52Low":5.485,"pbRate":"0.97","week52High":53.88,"institutionHeld":0.0223,"latestPrice":9.84,"committee":0.084175,"eps":-4.225857,"divideRate":0,"volume":44503,"delay":0,"ttmEps":-4.225857,"open":10.18,"prevYearClose":19.39,"prevWeekClose":10.09,"prevMonthClose":10.26,"prevQuarterClose":10.26,"fiveDayClose":9.3,"twentyDayClose":12.5,"sixtyDayClose":12.67},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":1877171755,"employeeNum":28,"address":"855 Oak Grove Avenue,Suite 100,Menlo Park,California,United States","zipCode":"94025","officePhone":"(650) 606-7910"},"stockCompanyDetail":{"websiteUrl":"http://orukatx.com","stockEarnings":[{"period":"1week","weight":0.0944},{"period":"1month","weight":-0.1141},{"period":"3month","weight":-0.1723},{"period":"6month","weight":-0.6395},{"period":"1year","weight":-0.7584},{"period":"ytd","weight":-0.4796}],"compareEarnings":[{"period":"1week","weight":0.046},{"period":"1month","weight":-0.0316},{"period":"3month","weight":-0.0943},{"period":"6month","weight":-0.049},{"period":"1year","weight":0.0936},{"period":"ytd","weight":-0.0605}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Oruka Therapeutics, Inc.公司根据日期为2008年9月24日的协议和合并重组计划的条款完成了与ARCA Colorado的业务合并（合并），并于2008年10月28日进行了修订，其中Nuvelo，Inc.的全资子公司与ARCA Colorado合并，ARCA Colorado在合并后继续作为存续公司和Nuvelo，Inc.的全资子公司。紧随合并后，该公司从Nuvelo，Inc.更名为ARCA Biopharma，Inc.。Nuvelo最初注册成立为HYSEQ。该公司是一家临床阶段的生物制药公司，专注于开发针对银屑病、炎症和免疫学适应症的新型单克隆抗体疗法。","yearOnYearQuotes":[{"month":1,"riseRate":0.3125,"avgChangeRate":0.038367},{"month":2,"riseRate":0.352941,"avgChangeRate":-0.074511},{"month":3,"riseRate":0.352941,"avgChangeRate":-0.027833},{"month":4,"riseRate":0.529412,"avgChangeRate":0.094265},{"month":5,"riseRate":0.5,"avgChangeRate":0.09678},{"month":6,"riseRate":0.25,"avgChangeRate":0.477078},{"month":7,"riseRate":0.5,"avgChangeRate":0.014024},{"month":8,"riseRate":0.0625,"avgChangeRate":-0.146138},{"month":9,"riseRate":0.3125,"avgChangeRate":-0.080322},{"month":10,"riseRate":0.4375,"avgChangeRate":-0.053682},{"month":11,"riseRate":0.625,"avgChangeRate":0.003334},{"month":12,"riseRate":0.5,"avgChangeRate":-0.003439}],"exchange":"NASDAQ","name":"ORUKA THERAPEUTICS INC","nameEN":"ORUKA THERAPEUTICS INC"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"ORKA\",market:\"US\",,,undefined,":{"directors":[{"name":"Michael R. Bristow","position":"President and Chief Executive Officer and Director"},{"name":"Robert E. Conway","position":"Director, Chairman"},{"name":"Anders Hove","position":"Director"},{"name":"Dan J. Mitchell","position":"Director"},{"name":"Jacob Ma Weaver","position":"Director"},{"name":"James Flynn","position":"Director"},{"name":"Linda Grais","position":"Director"},{"name":"Raymond L. Woosley","position":"Director"}],"executives":[{"name":"Michael R. Bristow","position":"President and Chief Executive Officer and Director"},{"name":"Thomas A. Keuer","position":"Chief Operating Officer"},{"name":"C. Jeffrey Dekker","position":"Chief Financial Officer"}]},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ORKA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-09-03","symbol":"ORKA","defaultRemindTime":1725370200000,"type":"split","dateTimestamp":1725336000000,"forFactor":12,"toFactor":1,"ratio":12},{"date":"2024-08-29","symbol":"ORKA","amount":1.613,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-08-26","defaultRemindTime":1724938200000,"name":"方舟生物医药","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-08-28","payableDate":"2024-08-26","currency":"USD","dateTimestamp":1724904000000,"payDate":"2024-08-28"},{"market":"US","date":"2024-08-01","symbol":"ORKA","fiscalQuarterEnding":"2024/06","expectedEps":null,"name":null,"time":"盘后","type":"earning","dateTimestamp":1722484800000,"reportTimeType":"post","actualEps":-0.18},{"market":"US","date":"2024-04-25","symbol":"ORKA","fiscalQuarterEnding":"2024/03","expectedEps":null,"name":null,"time":"盘后","type":"earning","dateTimestamp":1714017600000,"reportTimeType":"post","actualEps":-0.14},{"market":"US","date":"2024-02-01","symbol":"ORKA","fiscalQuarterEnding":"2023/12","expectedEps":null,"name":null,"time":"盘后","type":"earning","dateTimestamp":1706763600000,"reportTimeType":"post","actualEps":-0.08}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ORKA\",market:\"US\",,,undefined,":[{"executeDate":"2024-08-29","recordDate":"2024-08-26","paymentDate":"2024-08-28","value":1.613,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ORKA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.625,"buy":0.375,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.625,"analysts":8,"updateTime":1738641600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ORKA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ORKA","date":"2025-04-25","current":-4.304201,"percent":0.484848,"low":-5.124049,"twenty":-4.810047,"median":-4.25501,"eighty":-3.440082,"high":-2.779284,"avg":-4.125453,"sd":0.690217,"marketCap":393125355},"quantilePoints":[{"date":"2025-03-14","current":-4.566552,"twenty":-4.600166,"median":-4.533759,"eighty":-4.155287,"marketCap":417087281},{"date":"2025-03-21","current":-4.898591,"twenty":-4.788731,"median":-4.634189,"eighty":-4.465422,"marketCap":447414094},{"date":"2025-03-28","current":-4.898591,"twenty":-4.90187,"median":-4.734621,"eighty":-4.543597,"marketCap":447414094},{"date":"2025-04-04","current":-3.656521,"twenty":-4.90187,"median":-4.68543,"eighty":-4.155287,"marketCap":333969349},{"date":"2025-04-11","current":-3.021139,"twenty":-4.898591,"median":-4.546056,"eighty":-3.567158,"marketCap":275936558},{"date":"2025-04-17","current":-3.529445,"twenty":-4.883833,"median":-4.205819,"eighty":-3.28595,"marketCap":322362791},{"date":"2025-04-25","current":-4.304201,"twenty":-4.810047,"median":-4.25501,"eighty":-3.440082,"marketCap":393125355}],"updateTime":1745858099342}}}